U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975020) titled 'Pilot-Study for the Comparison of Biomarkers Between Regular Cannabis Users and Non-Users' on April 11.
Brief Summary: The relevance of driving under the influence of cannabis is becoming increasingly important in the context of legalization. However, the measurement of tetrahydrocannabinol (THC) blood concentration is an inadequate marker for assessing driving impairment. Currently, there is no reliable marker available for estimating the time of last cannabis inhalation, which would provide a promising tool for regulating driving under the influence of cannabis. This pilot study aims to explore potential biomarkers and factors that...